CIK 0001404644
- Non-accelerated filer
- Smaller reporting company
Neurogene Inc.
Sign in to watch- Ticker
- NGNE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 980542593
- Phone
- +1 877-237-5020
- Business address
- 535 W 24TH STREET, 5TH FLOOR, NEW YORK, NY, 10011
- Former names
- Neoleukin Therapeutics, Inc., AQUINOX PHARMACEUTICALS, INC, AQUINOX PHARMACEUTICALS (USA) INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-04-03 | Patel Priti Former Chief Medical Officer | Sale | −3,769 | $0.69 | $3K | 37,313 |
| 2023-03-31 | Patel Priti Former Chief Medical Officer | Exercise or conversion | +10,000 | 41,082 | ||
| 2023-03-31 | Patel Priti Former Chief Medical Officer | Exercise or conversion · Restricted Stock Units | −10,000 | 0 | ||
| 2023-02-02 | Patel Priti Chief Medical Officer | Sale | −14,380 | $0.60 | $9K | 31,082 |
| 2023-02-01 | Patel Priti Chief Medical Officer | Exercise or conversion | +35,000 | 45,462 | ||
| 2023-02-01 | Patel Priti Chief Medical Officer | Exercise or conversion · Restricted Stock Units | −35,000 | 35,000 | ||
| 2022-08-02 | Patel Priti Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +250,000 | 250,000 | ||
| 2022-05-02 | Patel Priti Chief Medical Officer | Sale | −5,538 | $1.22 | $7K | 6,462 |
| 2022-04-30 | Patel Priti Chief Medical Officer | Exercise or conversion | +10,000 | 12,000 | ||
| 2022-04-30 | Patel Priti Chief Medical Officer | Exercise or conversion · Restricted Stock Units | +10,000 | 10,000 | ||
| 2022-02-01 | Patel Priti Chief Medical Officer | Grant or award · Restricted Stock Units | +70,000 | 70,000 | ||
| 2021-08-03 | Patel Priti Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2021-04-30 | Patel Priti Chief Medical Officer | Grant or award · Restricted Stock Units | +20,000 | 20,000 | ||
| 2021-04-30 | Patel Priti Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +475,000 | 475,000 |
Page 1 of 1 · 14 trades